We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
CIRS

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Algorithm Examines Structural MRI Scans of Brain to Identify Patients in Early Stages of Mental Illness

By MedImaging International staff writers
Posted on 18 Apr 2022
Print article
Image: Grey matter volume could inform treatment decisions for developing mental health disorders (Photo courtesy of Pexels)
Image: Grey matter volume could inform treatment decisions for developing mental health disorders (Photo courtesy of Pexels)

A new study has shown that by examining structural MRI scans of the brain, it’s possible to identify patients most susceptible to poor outcomes. By identifying these patients in the early stages of their illness, clinicians will be able to offer more targeted and effective treatments.

In the study, researchers at the University of Birmingham (Edgbaston, UK) used data from around 300 patients with recent onset psychosis and recent onset depression taking part in the PRONIA study. PRONIA is a European Union-funded cohort study investigating prognostic tools for psychoses which is taking place across seven European research centers, including Birmingham. The researchers used a machine learning algorithm to assess data from patients’ brain scans and sort these into groups, or clusters. Two clusters were identified based on the scans, each of which contained both patients with psychosis and patients with depression. Each cluster revealed distinctive characteristics which related strongly to their likelihood of recovery.

In the first cluster, lower volumes of grey matter - the darker tissue inside the brain involved in muscle control and functions such as memory, emotions, and decision-making - were associated with patients who went on to have poorer outcomes. In the second group, in contrast, higher levels of grey matter signaled patients who were more likely to recover well from their illness. A second algorithm was then used to predict the patients’ condition nine months following the initial diagnosis. The researchers found a higher level of accuracy in predicting outcomes when using the biologically based clusters compared to traditional diagnostic systems.

Evidence also showed that patients in the cluster with lower volumes of grey matter in their brain scans may have higher levels of inflammation, poorer concentration, and other cognitive impairments previously associated with depression and schizophrenia. Finally, the team tested the clusters in other large cohort studies in Germany and the US and was able to show that the same identified clusters could be used to predict patient outcomes. The next step for the team is to start to validate the clusters in the clinic, gathering patient data in real time, before planning larger scale clinical trials.

“Currently, the way we diagnose most mental health disorders is based on a patient’s history, symptoms, and clinical observations, rather than on biological information,” said Paris Alexandros Lalousis, School of Psychology. “That means patients might have similar underlying biological mechanisms in their illness, but different diagnoses. By understanding those mechanisms more fully, we can give clinicians better tools to use in planning treatments.”

“While the PRONIA study contained people who were recently diagnosed with their illness, the other datasets we used contained people with chronic conditions,” added Lalousis. “We found that the longer the duration of illness, the more likely it was that a patient would fit into the first cluster with lower grey matter volume. That really adds to the evidence that structural MRI scans may be able to offer useful diagnostic information to help guide targeted treatment decisions.”

Related Links:
University of Birmingham 


Print article
Radcal
Sun Nuclear

Channels

Radiography

view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more

Ultrasound

view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.